NTRK2 and Stroke: After the middle cerebral artery occlusion (MCAO), the stroke rats received a combination therapy with AAV-BDNF and AAV-TrkB, and they showed significantly improved upper-limb motor functional recovery and neurotransmission efficiency compared to the AAV vector treatment alone.